Romper un cristal con un grito es una escena clásica en películas y series, pero ¿es posible lograrlo en la vida real? Desde el punto de vista científico, esta cuestión ha sido motivo de curiosidad y experimentación durante décadas. Conozcamos la f&ia …
¿Es posible romper un cristal con un grito muy agudo? La ciencia detrás del mito Read More »
A lo largo de la historia, diversas enfermedades han afectado a la humanidad de formas devastadoras. Algunas actúan de manera silenciosa y progresiva, mientras que otras se manifiestan de manera fulminante, acabando con la vida de las personas en cuestión de días o incluso horas …
Titán, la mayor luna de Saturno, es uno de los cuerpos más enigmáticos del sistema solar y un lugar de gran interés para la comunidad científica. Su paisaje alienígena, compuesto por mares de metano, dunas de hidrocarburos y montañas de hielo, lo conv …
The sale of Collaborative Health Systems to value-based care firm Astrana Health comes after Centene has divested a number of non-core assets in recent years.
Centene completes sale of management services subsidiary Read More »
It’s a loss for the Biden administration, which has tried to require states to provide abortions for emergency care since Roe v. Wade was overturned.
Supreme Court declines to weigh in on Texas emergency abortion case Read More »
The FDA has authorized nearly 1,000 medical devices with artificial intelligence features as companies including GE Healthcare and Siemens Healthineers build out their AI efforts.
The number of AI medical devices has spiked in the past decade Read More »
The trial will compare the therapy to radical prostatectomy and could unlock a market that analysts value at $500 million.
Procept secures FDA approval to study surgical robot in prostate cancer Read More »
After four patient deaths, Kezar’s lupus trial is officially on hold, sparking investor Kevin Tang’s interest for acquisition.
Concentra Spies New Target After Kezar’s Lupus Trial Hold Read More »
In a departure from most deals, startup insitro will in-license Lilly’s delivery technology for its investigational liver-targeted siRNA therapies. The pharma will be eligible for milestones and royalties down the line.
Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases Read More »
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector Read More »
